UNIVERSI
TÄ
TS-
BIBLIOTHEK
P
ADERBORN
Anmelden
Menü
Menü
Start
Hilfe
Blog
Weitere Dienste
Neuerwerbungslisten
Fachsystematik Bücher
Erwerbungsvorschlag
Bestellung aus dem Magazin
Fernleihe
Einstellungen
Sprache
Deutsch
Deutsch
Englisch
Farbschema
Hell
Dunkel
Automatisch
Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist
gegebenenfalls
nur via VPN oder Shibboleth (DFN-AAI) möglich.
mehr Informationen...
Universitätsbibliothek
Katalog
Suche
Details
Zur Ergebnisliste
Ergebnis 24 von 194
Datensatz exportieren als...
BibTeX
Locoregional treatment of peritoneal carcinomatosis from gastric cancer
Journal of surgical oncology, 2008-09, Vol.98 (4), p.273-276
Bozzetti, F.
Yu, W.
Baratti, Dario
Kusamura, Shigeki
Deraco, Marcello
2008
Volltextzugriff (PDF)
Details
Autor(en) / Beteiligte
Bozzetti, F.
Yu, W.
Baratti, Dario
Kusamura, Shigeki
Deraco, Marcello
Titel
Locoregional treatment of peritoneal carcinomatosis from gastric cancer
Ist Teil von
Journal of surgical oncology, 2008-09, Vol.98 (4), p.273-276
Ort / Verlag
Hoboken: Wiley Subscription Services, Inc., A Wiley Company
Erscheinungsjahr
2008
Quelle
Wiley Online Library Journals Frontfile Complete
Beschreibungen/Notizen
The authors reviewed the natural history and the main features of the peritoneal carcinomatosis from gastric cancer briefly and analyzed the pertinent literature concerning the locoregional modalities for prevention and for treatment. Results of the web based voting by experts were also summarized. As regards the peritoneal perfusion with cytotoxic drugs with or without hyperthermia for preventing peritoneal carcinomatosis in high risk patients, there are some randomized clinical trials and one meta‐analysis supporting a benefit of the procedure. However, disparity in methodology (drugs, dosage, duration of the treatment, addition of hyperthermia, etc.) precludes the adoption of a shared protocol to be used in the clinical practice in high risk patients. Once the peritoneal carcinomatosis is established, the approach reported in literature is the peritonectomy associated with hyperthermic perfusion. However, data supporting benefits are scanty, and limited to few centers with a specific experience in this field. With regard to the main questions addressed to the experts' panel and concerning the indications for treatment and methodology, there was a general consistency among the experts and agreement with the findings of the literature. The need for a large multicenter trial to confirm the benefit and risk of intraperitoneal chemotherapy was recognized by both the experts and the authors. J. Surg. Oncol. 2008;98:273–276. © 2008 Wiley‐Liss, Inc.
Sprache
Englisch
Identifikatoren
ISSN: 0022-4790
eISSN: 1096-9098
DOI: 10.1002/jso.21052
Titel-ID: cdi_proquest_miscellaneous_69476290
Format
–
Schlagworte
Carcinoma - secondary
,
Carcinoma - therapy
,
Chemotherapy, Adjuvant
,
Chemotherapy, Cancer, Regional Perfusion - methods
,
gastric neoplasm
,
Humans
,
Hyperthermia, Induced
,
Infusions, Parenteral
,
intraperitoneal chemotherapy
,
peritoneal carcinomatosis
,
Peritoneal Neoplasms - secondary
,
Peritoneal Neoplasms - therapy
,
peritonectomy
,
Stomach Neoplasms - pathology
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von
bX